Rakesh Popat
0000-0001-6553-4618
University College London
5 papers found
Refreshing results…
Thrombotic microangiopathy in untreated myeloma patients receiving carfilzomib, cyclophosphamide and dexamethasone on the CARDAMON study
COVID‐19 and myeloma clinical research – experience from the CARDAMON clinical trial
First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia
Carfilzomib is an effective upfront treatment in AL amyloidosis patients with peripheral and autonomic neuropathy
Clinical benefit of depth of response for relapsed/refractory multiple myeloma patients treated on clinical trials: retrospective analysis from two tertiary centres
Missing publications? Search for publications with a matching author name.